Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"

Circ Res. 2019 Apr 26;124(9):e82-e83. doi: 10.1161/CIRCRESAHA.119.315053.

Authors

Christophe Guignabert¹, Ly Tu¹, Jean-Jacques Feige², Marc Humbert¹, Sabine Bailly²

Affiliations

¹ INSERM UMR_S 999, Université Paris-Sud, Université Paris-Saclay, AP-HP, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire Sévère, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
² Université Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, Grenoble, France.

PMID: 31021726
DOI: 10.1161/CIRCRESAHA.119.315053

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Growth Differentiation Factor 2*
Humans
Hypertension, Pulmonary*
Pulmonary Artery

Substances

Growth Differentiation Factor 2